Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rangering i aksjer #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aksjekurs
$4.84
Markedsverdi
$633.18M
Endring (1 dag)
3.20%
Endring (1 år)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Kategori

Healthcare
P/B-forhold for Exscientia plc (EXAI)
P/B-forhold per April 2026 TTM: 1.26
Ifølge Exscientia plc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 1.26. Ved slutten av 2022 hadde selskapet et P/B-forhold på 1.36.
P/B-historikk for Exscientia plc fra 2019 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 1.26 -27.40%
2023 1.74 28.33%
2022 1.36 -67.63%
2021 4.20 -85.97%
2020 29.94 -64.81%
2019 85.08 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.2875 318.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.074 380.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.5436 101.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5196 257.76%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5468 101.60%
AU